article thumbnail

Executives Shares 7 Life Sciences Predictions to Watch in 2023

HIT Consultant

The FDA and other governing bodies will increasingly hold pharma companies accountable for diversity in clinical trials. For progress to take place, companies will need to be held accountable for real, substantial changes to their clinical trial processes. Ariel Katz, CEO & Co-Founder at H1. Jane Myles, V.P.

article thumbnail

Reimagining The Future of Pharmacovigilance (PV): Regulations, Tech, Public Perceptions

HIT Consultant

The Covid-19 pandemic has led to a surge in innovation across the life sciences industry, including vaccines and treatments being developed, approved, manufactured and delivered at an unprecedented scale in a matter of months – truly a remarkable achievement, and a testament to human ingenuity. About Annette Williams.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Generative AI to bring 'transformative change,' says Froedtert/Inception Health CTO

Healthcare It News

By integrating genAI into the fabric of healthcare, we stand really on the brink of a new frontier in medicine and life sciences. If you consider the Health Insurance Portability and Accountability Act, this was a critical regulation that provided data privacy and security provisions for safeguarding medical information for patients.

article thumbnail

The Medical Device Regulation, COVID-19 and Brexit

Triage Health Law

Regulation 2020/561 (Regulation) was passed by the EU in April last year to take account of issues raised by the COVID-19 pandemic and to defer the date of application of certain provisions of Regulation 2017/745 (MDR) by one year.

article thumbnail

Aetion Acquires Synthetic Data Platform Replica Analytics

HIT Consultant

Fortune 50 companies already use Replica’s technology to enable fast and effective access to high utility, synthetic versions of health data across their organizations while meeting regulatory obligations and compliance with privacy laws like the Health Insurance Portability and Accountability Act (HIPAA) in the U.S.

article thumbnail

Sensitive Data Requires Great Responsibility: The Importance of ‘Privacy and Security by Design’ in Healthcare

HIT Consultant

This approach aligns with the principle of data minimization, a key aspect of privacy regulations like the General Data Protection Regulation (GDPR) and HIPAA. To hold organizations accountable to these cybersecurity best practices, it’s essential to regularly audit and test your systems.

article thumbnail

Ethics for AI in Health – A View From The World Health Organization

Health Populi

Moving to deployment and implementation, we can consider health ministries and departments, pharma and life science companies, health systems and hospitals, individual providers, and the developers and providers integrated into health systems.